- Filed
- May 7, 2025 12:00 AM ET
- Period of report
- —
On SEC.gov
Financials in this filing
| Metric | Period | Value |
|---|---|---|
| Shares Outstanding | Q2 2025 · Apr 30, 2025 | 37.07M sh |
| Long Term Debt | Q2 2025 · Mar 31, 2025 | $70.02M |
| Long Term Debt | Q2 2025 · Sep 30, 2024 | $123.19M |
| Cash And Equivalents | Q2 2025 · Mar 31, 2025 | $26.3M |
| Cash And Equivalents | Q2 2025 · Sep 30, 2024 | $27.51M |
| Current Liabilities | Q2 2025 · Mar 31, 2025 | $85.67M |
| Current Liabilities | Q2 2025 · Sep 30, 2024 | $89.34M |
| Total Liabilities | Q2 2025 · Mar 31, 2025 | $175.81M |
| Total Liabilities | Q2 2025 · Sep 30, 2024 | $234.04M |
| Current Assets | Q2 2025 · Mar 31, 2025 | $134.73M |
| Current Assets | Q2 2025 · Sep 30, 2024 | $154.45M |
| Total Assets | Q2 2025 · Mar 31, 2025 | $781.02M |
| Total Assets | Q2 2025 · Sep 30, 2024 | $815.08M |
| Shares Diluted | Q2 2025 · Mar 31, 2024 | 36.97M sh |
| Shares Diluted | Q2 2025 · Mar 31, 2024 | 36.86M sh |
| Stock Repurchased | Q2 2025 · Mar 31, 2024 | $2.78M |
| Capex | Q2 2025 · Mar 31, 2024 | $803K |
| Operating Cash Flow | Q2 2025 · Mar 31, 2024 | $31.73M |
| Stockholders Equity | Q2 2025 · Mar 31, 2024 | $549.63M |
| Stockholders Equity | Q2 2025 · Dec 31, 2023 | $542.08M |
| Stockholders Equity | Q2 2025 · Sep 30, 2023 | $540.49M |
| Eps Diluted | Q2 2025 · Mar 31, 2024 | $0.11 |
| Eps Diluted | Q2 2025 · Mar 31, 2024 | $0.03 |
| Eps Basic | Q2 2025 · Mar 31, 2024 | $0.11 |
| Eps Basic | Q2 2025 · Mar 31, 2024 | $0.03 |
| Sga Expense | Q2 2025 · Mar 31, 2024 | $18.58M |
| Sga Expense | Q2 2025 · Mar 31, 2024 | $33.27M |
| Net Income | Q2 2025 · Mar 31, 2024 | $3.99M |
| Net Income | Q2 2025 · Mar 31, 2024 | $940K |
| Operating Income | Q2 2025 · Mar 31, 2024 | $8.15M |
| Operating Income | Q2 2025 · Mar 31, 2024 | $20.28M |
| Gross Profit | Q2 2025 · Mar 31, 2024 | $62.32M |
| Gross Profit | Q2 2025 · Mar 31, 2024 | $123.42M |
| Cost Of Revenue | Q2 2025 · Mar 31, 2024 | $45.38M |
| Cost Of Revenue | Q2 2025 · Mar 31, 2024 | $90.37M |